TP53 and breast cancer: Indeed, in a panel of primary BC lines, we could readily unmask reduced sensitivity to genotoxic agents in the Numb-1/2LOW subgroup, which could be rescued by Nutlin treatment, thus directly linking this phenotype to p53 downmodulation.